Navigation Links
In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors
Date:12/16/2009

ealthcare in 1999. Prior to joining OEC, Dr. Pepper spent 15 years with The BOC Group, Plc., where he served as president of Ohmeda Medical Devices, the healthcare subsidiary of BOC responsible for international selling and distribution of medical devices, and as president of Ohmeda Medical Equipment, which was responsible for Ohmeda's monitoring and anesthesia equipment business.

Dr. Pepper has a BS/MS in Engineering Science from Florida State University, a PhD in Mechanical Engineering from Stanford University and an MBA from The Harvard Business School.

Dr. Pepper commented, "I am excited about this opportunity to add my knowledge and perspective to TechniScan, a company I have admired for quite some time. The images I have seen have impressive specificity and have the potential to change the ways that radiologists and oncologists detect cancer in the breast." Pepper continued, "The TechniScan Board has outstanding depth and diversity of perspective. I am honored to be a part of the group and I feel confident that, with our collective experience, we can take TechniScan and help make its imaging modality the premier method for post-mammographic lesion detection for women."

About TechniScan, Inc.

Based in Salt Lake City, Utah, TechniScan, Inc. is a medical device company engaged in the development and commercialization of a non-invasive imaging tool designed to provide physicians with automated ultrasound images of the human breast. The system, known as SVARA (TM), uses a process called Warm Bath Ultrasound (WBU(TM)) to provide physicians with automated, 3D, ultrasound images of the physical structures within the breast. TechniScan's WBU(TM) imaging device (SVARA (TM)) is limited by US law to investigational use unless, and until, cleared by the FDA.

For more information, please visit

SOURCE TechniScan, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Womens Sexual Health Company Changes Name in Preparation for Market Entry
2. Face Masks Fly Off Shelves in Preparation for Flu Season
3. CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts
4. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
5. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
6. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
7. AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 Onko-Sure(TM) Cancer Test
8. Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
9. Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
10. Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays
11. Wayne County Partners With TechTown to Launch Global Stem Cell Innovation and Commercialization Lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015 LifeScienceIndustryResearch.com ... Research Report on Global and China Lysine Industry ... a professional and the deep research report in ... Lysine basic information including definition, classification specifications, application, ... US, Europe , ...
(Date:4/17/2015)... 17, 2015 CVS Health Corporation (NYSE: ... Friday, May 1, 2015, at 8:30 a.m. (EDT) with ... results. An audio webcast of the conference ... portion of the CVS Health website for all interested ... This webcast will be archived and available on the ...
(Date:4/17/2015)... , April 17, 2015  Trovagene, Inc., ... announced today that clinical data presented at the ... its urine-based Precision Cancer Monitoring ℠ (PCM) ... monitoring of EGFR T790M mutations in ... Detection of EGFR T790M Mutation in Urinary Circulating ...
Breaking Medicine Technology:Lysine Market International (US, Europe, Japan) Research Analysis 2Lysine Market International (US, Europe, Japan) Research Analysis 3Lysine Market International (US, Europe, Japan) Research Analysis 4Lysine Market International (US, Europe, Japan) Research Analysis 5Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
... 2011 Visionary Pharmaceuticals, Inc., announced today that ... a consortium of Angel Investors. The company is ... retinoic acid related orphan receptor (ROR) modulators targeting ... disorders including rheumatoid arthritis, multiple sclerosis, psoriasis and ...
... Ind., July 26, 2011 Symmetry Medical Inc. (NYSE: ... the global orthopaedic device industry and other medical markets, announced ... for the period ending July 2, 2011 before the market ... an accompanying conference call at 8:00 a.m. ET on Thursday, ...
Cached Medicine Technology:Visionary Pharmaceuticals, Inc., Announces Initial Seed Round Investments and the Launch of TH17 Autoimmune Disease Research Activities 2Symmetry Medical to Report Second Quarter 2011 Financial Results on August 4, 2011 2
(Date:4/17/2015)... April 17, 2015 Alcohol and Violence ... (NCADD) notes that drinking and driving has been the ... the same time, the link between alcohol and crime ... abuse and violence and sexual assault, and their relationship ... the NCADD, 5.3 million adults in America were drinking ...
(Date:4/17/2015)... From the day Dr. Todd Phillips founded The ... has empowered young people to create meaningful change in their ... water and the Gospel to all of Liberia by 2020 ... and 27, students, faculty and staff raised $21,000 through the ... and the Good News of Jesus. , During the ...
(Date:4/17/2015)... Representatives Jim Himes (D-CT) and Ed ... HR 1849 in congress on April 16, 2015 in ... patients with the genetic disease. , The bill, ... the first to create a federally led and financed ... hemorrhagic telangiectasia. This would effectively prevent premature death and ...
(Date:4/17/2015)... At the end of February 2015, Choices Recovery ... the Oscars” in the Stardust Penthouse on the rooftop ... Los Angeles skyline. These events honoring the 2015 Oscar ... producer of sustainable product placement in TV and film. ... of eco-friendly and socially conscious products and services, the ...
(Date:4/17/2015)... Baptist Health and The University of Texas ... designed to transform oncology care in northeast Florida and ... create a joint cancer program to enhance patient access ... MD Anderson Cancer Center is anticipated to open in ... highly coordinated, multidisciplinary cancer care for adults in the ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3
... with first product sales since 2005, SEATTLE, May ... reported financial results for the quarter ended,March 31, 2008. ... $20,000 for the first quarter of 2007. Gross product ... first quarter of 2008., Total operating expenses increased ...
... Holdings, Inc. ("Holdings",or the "Company"), the parent company ... nation,s largest cancer services companies, reported revenue of,$810.6 ... cash flow of,$50.9 million for the quarter ended ... include those of US Oncology, its wholly-owned,subsidiary, through ...
... CorVel Corporation,(Nasdaq: CRVL ) announced today that Gordon ... Bank of America 2008 Health Care Services,Conference on Tuesday, ... be,held at the Four Seasons Hotel in Las Vegas, ... through a webcast on,CorVel,s website, http://www.corvel.com . To ...
... result of San Diego State,University,s interim suspension ... supports the decisions of our,member fraternities to ... parties accountable for their actions. The NIC, ... with our member organizations and San,Diego State ...
... Inter-Con Security Officers Report They Don,t Have Healthcare, ... OAKLAND, Calif., May 7 In the ... increasing,number of security officers report they either don,t ... their families., Kaiser contractor Inter-Con Security is ...
... ALEXANDRIA, Va., May 7 The American Physical,Therapy ... coalition of,health and consumer groups to advocate for ... Safety of Seniors Act., In remarks during ... and National Falls Free Coalition representative Bonita,Lynn Beattie, ...
Cached Medicine News:Health News:Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results 2Health News:Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results 3Health News:Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results 4Health News:Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results 5Health News:Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results 6Health News:US Oncology Reports First Quarter 2008 Results 2Health News:US Oncology Reports First Quarter 2008 Results 3Health News:US Oncology Reports First Quarter 2008 Results 4Health News:US Oncology Reports First Quarter 2008 Results 5Health News:US Oncology Reports First Quarter 2008 Results 6Health News:US Oncology Reports First Quarter 2008 Results 7Health News:US Oncology Reports First Quarter 2008 Results 8Health News:US Oncology Reports First Quarter 2008 Results 9Health News:US Oncology Reports First Quarter 2008 Results 10Health News:US Oncology Reports First Quarter 2008 Results 11Health News:US Oncology Reports First Quarter 2008 Results 12Health News:US Oncology Reports First Quarter 2008 Results 13Health News:US Oncology Reports First Quarter 2008 Results 14Health News:US Oncology Reports First Quarter 2008 Results 15Health News:US Oncology Reports First Quarter 2008 Results 16Health News:US Oncology Reports First Quarter 2008 Results 17Health News:CorVel Announces Appearance at Bank of America Health Care Conference 2Health News:Workers With No Healthcare Protecting Kaiser Facilities, Security Contractor May Be Misleading California's Largest Healthcare Provider 2Health News:Physical Therapist Stresses Funding for Falls Prevention at National Safety Council Briefing 2
For injecting viscoelastic to all meridians of the anterior chamber and to coat intraocular lenses. 27G x 7/8in (.40 x 22mm), angled 10mm from end....
Cannula tip is specially rounded, extra smooth for safe insertion through wound and manipulation in the anterior chamber. 27G x 7/8 in (.40 x 22mm)....
For injecting anesthetics into the muscle cone. 23G x 1 1/2 in (.60 x 38mm)...
... (Electronystagmography) is a complete vestibular diagnostic ... eye movements collected via electrodes. Its ... to use. Saccade, tracking and Slow ... interpretation is facilitated by graphic comparison ...
Medicine Products: